IBT

International Biotechnology Trust Portfolio holdings

AUM $297M
1-Year Est. Return 17.25%
This Quarter Est. Return
1 Year Est. Return
+17.25%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$297M
AUM Growth
-$31.7M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
70
New
Increased
Reduced
Closed

Top Buys

1
+$8.41M
2
+$8.23M
3
+$7.51M
4
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$7.34M
5
GILD icon
Gilead Sciences
GILD
+$6.67M

Top Sells

1
+$14.9M
2
+$11.8M
3
+$10.2M
4
HRMY icon
Harmony Biosciences
HRMY
+$8.39M
5
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$7.93M

Sector Composition

1 Healthcare 99.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
INSM icon
51
Insmed
INSM
$34.5B
$1.01M 0.34%
40,100
BPMC
52
DELISTED
Blueprint Medicines
BPMC
$1M 0.34%
+20,000
AKRO icon
53
Akero Therapeutics
AKRO
$4.3B
$935K 0.32%
18,489
-60,000
KZR icon
54
Kezar Life Sciences
KZR
$30.5M
$831K 0.28%
+70,383
NTLA icon
55
Intellia Therapeutics
NTLA
$2.67B
$758K 0.26%
24,000
PRTA icon
56
Prothena Corp
PRTA
$543M
$723K 0.24%
+15,000
AGIO icon
57
Agios Pharmaceuticals
AGIO
$2.41B
$594K 0.2%
24,000
BEAM icon
58
Beam Therapeutics
BEAM
$2.61B
$565K 0.19%
23,500
VTYX icon
59
Ventyx Biosciences
VTYX
$285M
$521K 0.18%
15,000
VIR icon
60
Vir Biotechnology
VIR
$806M
$440K 0.15%
+47,000
IMAB
61
I-MAB
IMAB
$756M
$410K 0.14%
310,499
PTCT icon
62
PTC Therapeutics
PTCT
$5.31B
$381K 0.13%
17,000
ARVN icon
63
Arvinas
ARVN
$711M
$334K 0.11%
17,000
PTGX icon
64
Protagonist Therapeutics
PTGX
$4.71B
$332K 0.11%
19,900
RLMD icon
65
Relmada Therapeutics
RLMD
$66.7M
$30K 0.01%
10,000
APLS icon
66
Apellis Pharmaceuticals
APLS
$3.05B
– –
-129,700
HCM icon
67
HUTCHMED
HCM
$2.65B
– –
-68,000
SAGE
68
DELISTED
Sage Therapeutics
SAGE
– –
-20,000
TVTX icon
69
Travere Therapeutics
TVTX
$2.45B
– –
-441,019
HZNP
70
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
– –
-67,000
1 2
3